SODIUM PHENYLBUTYRATE

SODIUM PHENYLBUTYRATE was reported 422 times

SODIUM PHENYLBUTYRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD AMINO ACID LEVEL DECREASED 1 0.3333
1 NEONATAL HAEMOCHROMATOSIS 1 0.2500
2 HYPERAMMONAEMIC CRISIS 16 0.1495
3 CARNITINE ABNORMAL 1 0.1250
4 ORNITHINE TRANSCARBAMOYLASE DEFICIENCY 5 0.1220
5 ARGININOSUCCINATE SYNTHETASE DEFICIENCY 1 0.0769
6 OROTICACIDURIA 1 0.0714
7 UREA CYCLE DISORDER 2 0.0417
8 METASTASES TO REPRODUCTIVE ORGAN 1 0.0385
9 AMINO ACID METABOLISM DISORDER 1 0.0256
10 CRANIOPLASTY 1 0.0200
11 CENTRAL NERVOUS SYSTEM INJURY 1 0.0154
12 PRODUCT DOSE CONFUSION 5 0.0141
13 DRUG METABOLITE LEVEL HIGH 1 0.0119
14 HYPERAMMONAEMIA 57 0.0114
15 AMINO ACID LEVEL ABNORMAL 1 0.0103
16 AMINO ACID LEVEL INCREASED 7 0.0094
17 CATHETER SITE OEDEMA 1 0.0092
18 AMINO ACID LEVEL DECREASED 3 0.0089
19 PRODUCT STERILITY ISSUE 1 0.0081
20 DENTAL PROSTHESIS USER 1 0.0079
21 DRUG NAME CONFUSION 1 0.0079
22 ALKALOSIS HYPOCHLORAEMIC 1 0.0071
23 ELECTROCARDIOGRAM POOR R-WAVE PROGRESSION 1 0.0068
24 ACUTE TONSILLITIS 1 0.0063
25 AMMONIA INCREASED 32 0.0063
26 CENTRAL NERVOUS SYSTEM NEOPLASM 1 0.0062
27 GASTROINTESTINAL MUCORMYCOSIS 1 0.0060
28 INTERNAL HERNIA 1 0.0060
29 CARNITINE DEFICIENCY 1 0.0058
30 HAEMOCONCENTRATION 1 0.0058
31 ANTICONVULSANT DRUG LEVEL ABNORMAL 1 0.0057
32 RICKETS 1 0.0053
33 ANAPLASTIC LARGE-CELL LYMPHOMA 1 0.0042
34 DRUG LABEL CONFUSION 1 0.0040
35 MENINGORRHAGIA 1 0.0040
36 KYPHOSCOLIOSIS 1 0.0038
37 ACIDOSIS HYPERCHLORAEMIC 2 0.0034
38 POST PROCEDURAL PNEUMONIA 1 0.0033
39 HEPATITIS ALCOHOLIC 1 0.0031
40 MENTAL RETARDATION 1 0.0028
41 MILIA 1 0.0028
42 PORTAL VENOUS GAS 1 0.0028
43 ERYTHROMELALGIA 1 0.0027
44 HEMIANOPIA HOMONYMOUS 2 0.0027
45 JOINT HYPEREXTENSION 1 0.0026
46 DISSEMINATED MUCORMYCOSIS 1 0.0025
47 TRANSIENT TACHYPNOEA OF THE NEWBORN 1 0.0025
48 UPPER RESPIRATORY TRACT INFLAMMATION 3 0.0025
49 MENINGEAL DISORDER 1 0.0025
50 LARYNGEAL PAIN 1 0.0025
51 NECROTISING ENTEROCOLITIS NEONATAL 1 0.0025
52 USE OF ACCESSORY RESPIRATORY MUSCLES 1 0.0024
53 BONE SCAN ABNORMAL 1 0.0024
54 PNEUMATOSIS 1 0.0022
55 MULTIPLE DRUG OVERDOSE ACCIDENTAL 1 0.0022
56 NECROSIS ISCHAEMIC 1 0.0022
57 ANTINUCLEAR ANTIBODY INCREASED 2 0.0021
58 BRAIN DAMAGE 1 0.0020
59 TRACHEAL STENOSIS 1 0.0020
60 INFANTILE SPITTING UP 1 0.0019
61 RETROPERITONEAL LYMPHADENOPATHY 1 0.0019
62 LIFE SUPPORT 1 0.0018
63 FOOD AVERSION 3 0.0018
64 URINARY TRACT INFECTION FUNGAL 1 0.0017
65 HYPERAMMONAEMIC ENCEPHALOPATHY 3 0.0017
66 AORTIC CALCIFICATION 1 0.0017
67 AMBLYOPIA 1 0.0017
68 NECROTISING COLITIS 2 0.0016
69 OEDEMA GENITAL 1 0.0016
70 SKIN ODOUR ABNORMAL 6 0.0015
71 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
72 THYROID HORMONES DECREASED 1 0.0013
73 VERTEBRAL FORAMINAL STENOSIS 1 0.0012
74 PERITONSILLAR ABSCESS 1 0.0012
75 ABSCESS DRAINAGE 1 0.0012
76 TESTICULAR ATROPHY 1 0.0011
77 HYPERPLASIA 1 0.0011
78 LIVER TRANSPLANT 4 0.0011
79 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
80 PRINZMETAL ANGINA 1 0.0010
81 MUCOSAL ULCERATION 1 0.0010
82 RENAL TUBULAR ACIDOSIS 2 0.0009
83 SOFT TISSUE DISORDER 1 0.0009
84 PARESIS 2 0.0009
85 MOANING 1 0.0009
86 CARBON DIOXIDE DECREASED 1 0.0009
87 PRODUCT USE COMPLAINT 13 0.0008
88 INTRAVENTRICULAR HAEMORRHAGE 2 0.0008
89 WHITE MATTER LESION 1 0.0008
90 LIP HAEMORRHAGE 1 0.0008
91 MICROCEPHALY 1 0.0008
92 NON-HODGKIN'S LYMPHOMA 1 0.0008
93 GASTROENTERITIS NOROVIRUS 1 0.0008
94 LIP EXFOLIATION 1 0.0008
95 RETCHING 16 0.0007
96 ANION GAP INCREASED 1 0.0007
97 CENTRAL NERVOUS SYSTEM LYMPHOMA 1 0.0007
98 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 1 0.0007
99 HEAT STROKE 1 0.0007
100 TRANSCRIPTION MEDICATION ERROR 1 0.0006
101 OSTEOSCLEROSIS 1 0.0006
102 RESPIRATORY ALKALOSIS 1 0.0006
103 REFUSAL OF TREATMENT BY PATIENT 4 0.0006
104 ANTIBODY TEST POSITIVE 1 0.0006
105 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
106 SPLEEN DISORDER 1 0.0006
107 EROSIVE OESOPHAGITIS 1 0.0006
108 NEUROPATHY 1 0.0006
109 PSEUDOMONAL SEPSIS 1 0.0006
110 JUGULAR VEIN THROMBOSIS 1 0.0006
111 VOCAL CORD PARALYSIS 1 0.0006
112 LIVER TRANSPLANT REJECTION 1 0.0006
113 BONE LESION 2 0.0006
114 DEVELOPMENTAL DELAY 5 0.0006
115 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
116 BLOOD BICARBONATE DECREASED 1 0.0005
117 HYPOPROTEINAEMIA 1 0.0005
118 PURULENCE 1 0.0005
119 PROTHROMBIN TIME PROLONGED 3 0.0005
120 MUSCLE CONTRACTURE 1 0.0005
121 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
122 MICROCYTIC ANAEMIA 1 0.0005
123 HAEMODIALYSIS 4 0.0005
124 ANAEMIA MACROCYTIC 1 0.0005
125 PRODUCT TASTE ABNORMAL 6 0.0004
126 PERFORMANCE STATUS DECREASED 2 0.0004
127 TIBIA FRACTURE 2 0.0004
128 URINARY TRACT OBSTRUCTION 1 0.0004
129 TRANSPLANT 1 0.0004
130 EOSINOPHIL COUNT DECREASED 1 0.0004
131 INFREQUENT BOWEL MOVEMENTS 1 0.0004
132 GASTROINTESTINAL TUBE INSERTION 1 0.0004
133 VENTRICULAR HYPERTROPHY 1 0.0004
134 CATHETER SITE PAIN 1 0.0004
135 MUCORMYCOSIS 1 0.0004
136 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
137 BLOOD ALBUMIN DECREASED 3 0.0004
138 LEARNING DISABILITY 2 0.0004
139 BLOOD POTASSIUM ABNORMAL 1 0.0004
140 YAWNING 1 0.0004
141 HYPERLACTACIDAEMIA 1 0.0004
142 BLOOD SODIUM INCREASED 1 0.0004
143 BRADYPNOEA 1 0.0004
144 CLONUS 1 0.0004
145 RENAL TUBULAR DISORDER 1 0.0004
146 BLOOD URIC ACID INCREASED 2 0.0003
147 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
148 STRABISMUS 1 0.0003
149 URINE ANALYSIS ABNORMAL 1 0.0003
150 HYPERCAPNIA 1 0.0003
151 PORTAL HYPERTENSION 1 0.0003
152 BLOOD CREATININE DECREASED 1 0.0003
153 BRAIN OEDEMA 4 0.0003
154 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
155 LOOSE TOOTH 1 0.0003
156 PORTAL VEIN THROMBOSIS 1 0.0003
157 DEAFNESS NEUROSENSORY 1 0.0003
158 PROSTATE CANCER METASTATIC 1 0.0003
159 METASTASES TO SPINE 1 0.0003
160 NEOPLASM RECURRENCE 1 0.0003
161 MULTI-ORGAN FAILURE 5 0.0003
162 BRONCHIOLITIS 1 0.0003
163 METASTASIS 2 0.0003
164 PRODUCT SUPPLY ISSUE 2 0.0003
165 GASTROINTESTINAL PAIN 3 0.0003
166 CEREBRAL DISORDER 2 0.0003
167 IMPULSIVE BEHAVIOUR 1 0.0003
168 PROTEIN TOTAL DECREASED 1 0.0003
169 HEPATIC FAILURE 8 0.0003
170 CATHETER SITE INFECTION 1 0.0003
171 CLAVICLE FRACTURE 1 0.0003
172 EPIGASTRIC DISCOMFORT 1 0.0003
173 AFFECTIVE DISORDER 2 0.0003
174 BACTERAEMIA 3 0.0003
175 SKIN PAPILLOMA 1 0.0002
176 ENCEPHALOPATHY 6 0.0002
177 HYPERURICAEMIA 1 0.0002
178 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
179 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
180 GASTROINTESTINAL PERFORATION 1 0.0002
181 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
182 METASTATIC NEOPLASM 1 0.0002
183 HEPATIC LESION 1 0.0002
184 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
185 OCULAR ICTERUS 1 0.0002
186 CHAPPED LIPS 1 0.0002
187 PARONYCHIA 1 0.0002
188 ILEUS PARALYTIC 1 0.0002
189 GASTROENTERITIS VIRAL 4 0.0002
190 BRAIN NEOPLASM 2 0.0002
191 DIALYSIS 3 0.0002
192 CHOLESTASIS 4 0.0002
193 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
194 HOSPICE CARE 2 0.0002
195 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
196 SMALL FOR DATES BABY 1 0.0002
197 ABDOMINAL TENDERNESS 1 0.0002
198 HYPERNATRAEMIA 1 0.0002
199 THROAT IRRITATION 9 0.0002
200 BRAIN INJURY 2 0.0002
201 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
202 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
203 PETIT MAL EPILEPSY 1 0.0002
204 PRODUCT COLOUR ISSUE 1 0.0002
205 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
206 CACHEXIA 1 0.0002
207 TONSILLITIS 1 0.0002
208 BLOOD LACTIC ACID INCREASED 1 0.0002
209 NYSTAGMUS 1 0.0002
210 PRODUCT RESIDUE PRESENT 1 0.0002
211 HYDROCEPHALUS 1 0.0002
212 DEAFNESS UNILATERAL 1 0.0002
213 COAGULOPATHY 3 0.0002
214 INTRACRANIAL PRESSURE INCREASED 1 0.0002
215 MALNUTRITION 2 0.0002
216 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
217 PREMATURE LABOUR 1 0.0002
218 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
219 HYPERTONIA 1 0.0002
220 LETHARGY 10 0.0002
221 HYPERVENTILATION 1 0.0002
222 URINE ODOUR ABNORMAL 1 0.0002
223 ATAXIA 2 0.0002
224 SYMPTOM RECURRENCE 1 0.0002
225 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
226 DERMATITIS ACNEIFORM 1 0.0002
227 CARDIOMEGALY 2 0.0002
228 GENERALISED OEDEMA 2 0.0002
229 OLIGURIA 1 0.0002
230 SCREAMING 1 0.0002
231 METABOLIC ACIDOSIS 5 0.0002
232 HERPES SIMPLEX 1 0.0002
233 POLYP 1 0.0002
234 METASTASES TO LYMPH NODES 1 0.0001
235 PRODUCT LABEL ISSUE 1 0.0001
236 TACHYPNOEA 2 0.0001
237 DRUG TOXICITY 2 0.0001
238 ACUTE HEPATIC FAILURE 2 0.0001
239 TREATMENT NONCOMPLIANCE 8 0.0001
240 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
241 LARGE INTESTINE PERFORATION 1 0.0001
242 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
243 HEPATOCELLULAR INJURY 2 0.0001
244 EATING DISORDER 3 0.0001
245 GASTROENTERITIS 2 0.0001
246 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
247 TENDON PAIN 1 0.0001
248 OSTEOPENIA 2 0.0001
249 ACIDOSIS 1 0.0001
250 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
251 PROCEDURAL COMPLICATION 1 0.0001
252 HYPOKALAEMIA 6 0.0001
253 APNOEA 1 0.0001
254 LOW BIRTH WEIGHT BABY 1 0.0001
255 DECUBITUS ULCER 1 0.0001
256 ABNORMAL FAECES 1 0.0001
257 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
258 CIRCULATORY COLLAPSE 2 0.0001
259 HYPOPHAGIA 3 0.0001
260 VITAMIN D DECREASED 1 0.0001
261 ANURIA 1 0.0001
262 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
263 URINE OUTPUT DECREASED 1 0.0001
264 EOSINOPHILIA 2 0.0001
265 SEIZURE 13 0.0001
266 ANAL INCONTINENCE 1 0.0001
267 LIP DRY 1 0.0001
268 IRON DEFICIENCY ANAEMIA 1 0.0001
269 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
270 PERSONALITY CHANGE 1 0.0001
271 DECREASED APPETITE 25 0.0001
272 HEPATIC STEATOSIS 2 0.0001
273 ARTERIOSCLEROSIS 1 0.0001
274 INCREASED APPETITE 2 0.0001
275 ATELECTASIS 1 0.0001
276 SINUS BRADYCARDIA 1 0.0001
277 LABORATORY TEST ABNORMAL 3 0.0001
278 HYPOTONIA 1 0.0001
279 AGGRESSION 5 0.0001
280 IRRITABILITY 6 0.0001
281 APHASIA 3 0.0001
282 DRUG LEVEL DECREASED 1 0.0001
283 EPILEPSY 3 0.0001
284 MOTOR DYSFUNCTION 1 0.0001
285 INITIAL INSOMNIA 1 0.0001
286 POOR VENOUS ACCESS 1 0.0001
287 VENTRICULAR EXTRASYSTOLES 1 0.0001
288 PRODUCT ODOUR ABNORMAL 1 0.0001
289 JOINT DISLOCATION 1 0.0001
290 DYSGEUSIA 7 0.0001
291 DRUG INTOLERANCE 9 0.0001
292 PHARYNGITIS STREPTOCOCCAL 1 0.0001
293 SKIN LACERATION 1 0.0001
294 DENTAL CARIES 1 0.0001
295 FOOT DEFORMITY 1 0.0001
296 VIRAL INFECTION 3 0.0001
297 TRANSAMINASES INCREASED 2 0.0001
298 HEPATOTOXICITY 2 0.0001
299 SEPSIS 10 0.0001
300 VOMITING 42 0.0001
301 SKIN INFECTION 1 0.0001
302 INTESTINAL PERFORATION 1 0.0001
303 BLOOD CALCIUM DECREASED 1 0.0001
304 REBOUND EFFECT 1 0.0001
305 HEPATIC ENZYME INCREASED 6 0.0001
306 DERMATITIS CONTACT 1 0.0001
307 NEOPLASM 1 0.0001
308 GASTRIC HAEMORRHAGE 1 0.0001
309 ELECTROLYTE IMBALANCE 1 0.0001
310 SPLENOMEGALY 1 0.0001
311 COMA 4 0.0001
312 MUSCLE RIGIDITY 1 0.0001
313 WRIST FRACTURE 1 0.0001
314 BURSITIS 1 0.0001
315 ADRENAL INSUFFICIENCY 1 0.0001
316 HYPERGLYCAEMIA 3 0.0001
317 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
318 MUSCLE SPASTICITY 1 0.0001
319 PHARYNGITIS 1 0.0001
320 POISONING 1 0.0001
321 ROTATOR CUFF SYNDROME 1 0.0001
322 SKIN ULCER 2 0.0001
323 HIATUS HERNIA 1 0.0001
324 RESPIRATORY TRACT INFECTION 2 0.0001
325 NODULE 1 0.0001
326 BEDRIDDEN 1 0.0001
327 DISEASE PROGRESSION 9 0.0001
328 ADVERSE EVENT 7 0.0001
329 TOOTH INFECTION 1 0.0001
330 PULMONARY CONGESTION 1 0.0001
331 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
332 DISORIENTATION 3 0.0001
333 DYSMENORRHOEA 1 0.0001
334 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
335 HAIR TEXTURE ABNORMAL 1 0.0001
336 JAUNDICE 2 0.0001
337 DYSPHAGIA 7 0.0001
338 IMPAIRED GASTRIC EMPTYING 1 0.0001
339 AKATHISIA 1 0.0001
340 GINGIVAL BLEEDING 1 0.0001
341 SKIN LESION 2 0.0001
342 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
343 RESPIRATORY ARREST 2 0.0001
344 MENTAL STATUS CHANGES 2 0.0001
345 ORAL DISCOMFORT 1 0.0001
346 HUNGER 1 0.0001
347 PANCYTOPENIA 4 0.0001
348 WOUND 2 0.0001
349 DEVICE OCCLUSION 1 0.0001
350 BRONCHOSPASM 1 0.0001
351 PARALYSIS 1 0.0001
352 HYPERSOMNIA 2 0.0001
353 IMPAIRED QUALITY OF LIFE 1 0.0001
354 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
355 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
356 TACHYCARDIA 6 0.0001
357 BLOOD POTASSIUM DECREASED 2 0.0001
358 UNEVALUABLE EVENT 5 0.0001
359 INSURANCE ISSUE 1 0.0001
360 DEVICE RELATED INFECTION 1 0.0001
361 MUSCULOSKELETAL CHEST PAIN 1 0.0001
362 BASAL CELL CARCINOMA 1 0.0001
363 NERVOUS SYSTEM DISORDER 2 0.0001
364 BRAIN FOG 1 0.0001
365 DRUG-INDUCED LIVER INJURY 2 0.0001
366 RESPIRATORY TRACT CONGESTION 1 0.0001
367 CYSTITIS 2 0.0001
368 RHINORRHOEA 4 0.0001
369 HYPOGLYCAEMIA 3 0.0001
370 LACTIC ACIDOSIS 2 0.0001
371 DYSPEPSIA 6 0.0001
372 MANIA 1 0.0001
373 VENTRICULAR TACHYCARDIA 1 0.0001
374 DEHYDRATION 8 0.0001
375 BLOOD UREA INCREASED 1 0.0001
376 ABDOMINAL DISCOMFORT 10 0.0001
377 METRORRHAGIA 1 0.0001
378 ABDOMINAL PAIN UPPER 12 0.0001
379 NEOPLASM PROGRESSION 2 0.0001
380 LYMPHOCYTE COUNT DECREASED 1 0.0001
381 LYMPHADENOPATHY 2 0.0001
382 THERAPY INTERRUPTED 4 0.0001
383 OFF LABEL USE 49 0.0001
384 OSTEOMYELITIS 1 0.0001
385 BONE DISORDER 1 0.0001
386 RESPIRATORY FAILURE 4 0.0001
387 AGITATION 4 0.0001
388 BACTERIAL INFECTION 1 0.0001
389 HYPOCALCAEMIA 1 0.0001
390 FEELING JITTERY 1 0.0001
391 CONVULSION 3 0.0001
392 POST PROCEDURAL COMPLICATION 1 0.0001
393 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
394 CHOKING 1 0.0001
395 ALOPECIA 10 0.0001
396 SINUS DISORDER 1 0.0001
397 CATARACT 3 0.0001
398 BLOOD PRESSURE ABNORMAL 1 0.0001
399 PREGNANCY 1 0.0000
400 FEEDING DISORDER 1 0.0000
401 DYSKINESIA 2 0.0000
402 NEUTROPHIL COUNT DECREASED 2 0.0000
403 BODY TEMPERATURE INCREASED 1 0.0000
404 RIB FRACTURE 1 0.0000
405 ILLNESS 5 0.0000
406 CARDIAC ARREST 4 0.0000
407 TOOTH LOSS 1 0.0000
408 CARDIO-RESPIRATORY ARREST 2 0.0000
409 DERMATITIS 1 0.0000
410 IMPAIRED WORK ABILITY 1 0.0000
411 LIVER FUNCTION TEST INCREASED 1 0.0000
412 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
413 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
414 LIVER DISORDER 2 0.0000
415 TOOTH DISORDER 1 0.0000
416 NEOPLASM MALIGNANT 3 0.0000
417 ORAL PAIN 1 0.0000
418 RASH PAPULAR 1 0.0000
419 ADVERSE DRUG REACTION 4 0.0000
420 PANCREATITIS ACUTE 1 0.0000
421 SHOCK 1 0.0000
422 MUSCLE TWITCHING 1 0.0000
423 ABDOMINAL PAIN 10 0.0000
424 CONDITION AGGRAVATED 13 0.0000
425 ARRHYTHMIA 2 0.0000
426 DIARRHOEA 27 0.0000
427 MENTAL IMPAIRMENT 1 0.0000
428 DEATH 35 0.0000
429 BRONCHITIS 3 0.0000
430 ABASIA 1 0.0000
431 OSTEONECROSIS OF JAW 1 0.0000
432 EXTRAPYRAMIDAL DISORDER 1 0.0000
433 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
434 PNEUMONIA ASPIRATION 1 0.0000
435 SOMNOLENCE 8 0.0000
436 CELLULITIS 2 0.0000
437 LOSS OF CONSCIOUSNESS 5 0.0000
438 THERAPY CESSATION 2 0.0000
439 ERECTILE DYSFUNCTION 1 0.0000
440 UNRESPONSIVE TO STIMULI 1 0.0000
441 RASH GENERALISED 1 0.0000
442 HAEMATOMA 1 0.0000
443 ABDOMINAL DISTENSION 4 0.0000
444 MUCOSAL INFLAMMATION 1 0.0000
445 SPEECH DISORDER 2 0.0000
446 PANCREATITIS 2 0.0000
447 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
448 PAIN OF SKIN 1 0.0000
449 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
450 ANAEMIA 7 0.0000
451 MOOD ALTERED 1 0.0000
452 ABNORMAL DREAMS 1 0.0000
453 DEMENTIA 1 0.0000
454 OXYGEN SATURATION DECREASED 2 0.0000
455 HYPONATRAEMIA 2 0.0000
456 NAUSEA 28 0.0000
457 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
458 PAIN IN JAW 1 0.0000
459 FLATULENCE 2 0.0000
460 ANGINA PECTORIS 1 0.0000
461 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
462 PYREXIA 12 0.0000
463 LIVER FUNCTION TEST ABNORMAL 1 0.0000
464 BONE PAIN 2 0.0000
465 ASCITES 1 0.0000
466 URINARY INCONTINENCE 1 0.0000
467 RENAL INJURY 1 0.0000
468 RESPIRATORY DISORDER 1 0.0000
469 PREMATURE BABY 1 0.0000
470 STOMATITIS 2 0.0000
471 DRUG ADMINISTRATION ERROR 1 0.0000
472 NASOPHARYNGITIS 6 0.0000
473 EMOTIONAL DISORDER 1 0.0000
474 GYNAECOMASTIA 1 0.0000
475 WEIGHT DECREASED 9 0.0000
476 CONSTIPATION 7 0.0000
477 BONE DENSITY DECREASED 1 0.0000
478 PULMONARY EMBOLISM 3 0.0000
479 CONFUSIONAL STATE 5 0.0000
480 DEEP VEIN THROMBOSIS 2 0.0000
481 EXPIRED PRODUCT ADMINISTERED 1 0.0000
482 EYE PRURITUS 1 0.0000
483 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
484 URINARY TRACT INFECTION 5 0.0000
485 GASTRIC DISORDER 1 0.0000
486 HYPERKALAEMIA 1 0.0000
487 HEART RATE DECREASED 1 0.0000
488 PLATELET COUNT DECREASED 3 0.0000
489 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
490 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
491 CEREBRAL HAEMORRHAGE 1 0.0000
492 DRUG EFFECT INCOMPLETE 1 0.0000
493 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
494 PANIC ATTACK 1 0.0000
495 RESTLESSNESS 1 0.0000
496 INFLUENZA 3 0.0000
497 WEIGHT INCREASED 6 0.0000
498 DYSARTHRIA 1 0.0000
499 HOT FLUSH 2 0.0000
500 INTESTINAL OBSTRUCTION 1 0.0000
501 COLITIS 1 0.0000
502 HOSPITALISATION 4 0.0000
503 ARTHRITIS 2 0.0000
504 ABNORMAL BEHAVIOUR 1 0.0000
505 DRY MOUTH 2 0.0000
506 OEDEMA PERIPHERAL 3 0.0000
507 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
508 LUNG NEOPLASM MALIGNANT 1 0.0000
509 RHABDOMYOLYSIS 1 0.0000
510 OSTEOARTHRITIS 1 0.0000
511 RENAL FAILURE ACUTE 1 0.0000
512 VAGINAL HAEMORRHAGE 1 0.0000
513 RASH 10 0.0000
514 RENAL FAILURE 3 0.0000
515 COLITIS ULCERATIVE 1 0.0000
516 PULMONARY OEDEMA 1 0.0000
517 GASTROINTESTINAL DISORDER 2 0.0000
518 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
519 THERAPY NON-RESPONDER 1 0.0000
520 VISION BLURRED 3 0.0000
521 FATIGUE 17 0.0000
522 NEPHROLITHIASIS 1 0.0000
523 MUSCLE SPASMS 4 0.0000
524 TINNITUS 1 0.0000
525 HYPERSENSITIVITY 4 0.0000
526 RENAL DISORDER 1 0.0000
527 BLOOD CHOLESTEROL INCREASED 1 0.0000
528 COUGH 6 0.0000
529 CARDIAC DISORDER 2 0.0000
530 SWELLING 2 0.0000
531 PRODUCT USE ISSUE 4 0.0000
532 PRODUCTIVE COUGH 1 0.0000
533 BLOOD GLUCOSE DECREASED 1 0.0000
534 INFECTION 3 0.0000
535 SYNCOPE 2 0.0000
536 HYPOTENSION 4 0.0000
537 FLUID RETENTION 1 0.0000
538 BLOOD PRESSURE INCREASED 3 0.0000
539 CHEST DISCOMFORT 2 0.0000
540 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
541 PERIPHERAL SWELLING 3 0.0000
542 HEADACHE 12 0.0000
543 HAEMORRHAGE 2 0.0000
544 DERMATITIS ATOPIC 1 0.0000
545 DRUG EFFECT DECREASED 1 0.0000
546 DISTURBANCE IN ATTENTION 1 0.0000
547 PNEUMONIA 6 0.0000
548 RASH PRURITIC 1 0.0000
549 OEDEMA 1 0.0000
550 MALAISE 8 0.0000
551 TREMOR 3 0.0000
552 MEDICATION ERROR 1 0.0000
553 NECK PAIN 1 0.0000
554 BLISTER 1 0.0000
555 HERPES ZOSTER 1 0.0000
556 PRODUCT SUBSTITUTION ISSUE 1 0.0000
557 BACK PAIN 4 0.0000
558 BLADDER CANCER 1 0.0000
559 FEELING ABNORMAL 4 0.0000
560 THERAPEUTIC RESPONSE DECREASED 1 0.0000
561 VERTIGO 1 0.0000
562 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
563 DIZZINESS 8 0.0000
564 ASTHENIA 6 0.0000
565 GAIT DISTURBANCE 3 0.0000
566 INFUSION RELATED REACTION 1 0.0000
567 DRY SKIN 2 0.0000
568 PRODUCT QUALITY ISSUE 2 0.0000
569 MEMORY IMPAIRMENT 2 0.0000
570 INJURY 1 0.0000
571 SLEEP DISORDER 1 0.0000
572 MOBILITY DECREASED 1 0.0000
573 UNDERDOSE 1 0.0000
574 HALLUCINATION 1 0.0000
575 ACNE 1 0.0000
576 INCORRECT DOSE ADMINISTERED 3 0.0000
577 DRUG DOSE OMISSION BY DEVICE 1 0.0000
578 DRUG INTERACTION 2 0.0000
579 CARDIAC FAILURE 1 0.0000
580 DRUG DOSE OMISSION 2 0.0000
581 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
582 RENAL IMPAIRMENT 1 0.0000
583 INTENTIONAL PRODUCT MISUSE 1 0.0000
584 COVID-19 2 0.0000
585 DRUG WITHDRAWAL SYNDROME 1 0.0000
586 INSOMNIA 3 0.0000
587 DRUG INEFFECTIVE 14 0.0000
588 DYSPNOEA 6 0.0000
589 ANXIETY 3 0.0000
590 NEUROPATHY PERIPHERAL 1 0.0000
591 CONTUSION 1 0.0000
592 HEART RATE INCREASED 1 0.0000
593 SINUSITIS 1 0.0000
594 HAEMOGLOBIN DECREASED 1 0.0000
595 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
596 OVERDOSE 2 0.0000
597 FALL 3 0.0000
598 THROMBOCYTOPENIA 1 0.0000
599 ASTHMA 1 0.0000
600 MUSCULAR WEAKNESS 1 0.0000
601 CHILLS 1 0.0000
602 VISUAL IMPAIRMENT 1 0.0000
603 PRURITUS 3 0.0000
604 NEUTROPENIA 1 0.0000
605 PRODUCT DOSE OMISSION ISSUE 2 0.0000
606 PAIN IN EXTREMITY 2 0.0000
607 PAIN 4 0.0000
608 PARAESTHESIA 1 0.0000
609 TOXICITY TO VARIOUS AGENTS 1 0.0000
610 CEREBROVASCULAR ACCIDENT 1 0.0000
611 MYALGIA 1 0.0000
612 MYOCARDIAL INFARCTION 1 0.0000
613 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
614 CHEST PAIN 1 0.0000
615 BLOOD GLUCOSE INCREASED 1 0.0000
616 HYPERTENSION 1 0.0000
617 DEPRESSION 1 0.0000
618 ARTHRALGIA 1 0.0000